These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Genes influenced by MEF2C contribute to neurodevelopmental disease via gene expression changes that affect multiple types of cortical excitatory neurons. Cosgrove D; Whitton L; Fahey L; Ó Broin P; Donohoe G; Morris DW Hum Mol Genet; 2021 May; 30(11):961-970. PubMed ID: 32975584 [TBL] [Abstract][Full Text] [Related]
8. Genes positively regulated by Mef2c in cortical neurons are enriched for common genetic variation associated with IQ and educational attainment. Fahey L; Ali D; Donohoe G; Ó Broin P; Morris DW Hum Mol Genet; 2023 Nov; 32(22):3194-3203. PubMed ID: 37672226 [TBL] [Abstract][Full Text] [Related]
9. The Basu S; Ro EJ; Liu Z; Kim H; Bennett A; Kang S; Suh H J Neurosci; 2024 Jan; 44(5):. PubMed ID: 38123360 [TBL] [Abstract][Full Text] [Related]
10. Genotypes and Phenotypes of MEF2C Haploinsufficiency Syndrome: New Cases and Novel Point Mutations. Wan L; Liu X; Hu L; Chen H; Sun Y; Li Z; Wang Z; Lin Z; Zou L; Yang G Front Pediatr; 2021; 9():664449. PubMed ID: 34055696 [No Abstract] [Full Text] [Related]
11. Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models. Mohajeri K; Yadav R; D'haene E; Boone PM; Erdin S; Gao D; Moyses-Oliveira M; Bhavsar R; Currall BB; O'Keefe K; Burt ND; Lowther C; Lucente D; Salani M; Larson M; Redin C; Dudchenko O; Aiden EL; Menten B; Tai DJC; Gusella JF; Vergult S; Talkowski ME Am J Hum Genet; 2022 Nov; 109(11):2049-2067. PubMed ID: 36283406 [TBL] [Abstract][Full Text] [Related]
12. MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways. Paciorkowski AR; Traylor RN; Rosenfeld JA; Hoover JM; Harris CJ; Winter S; Lacassie Y; Bialer M; Lamb AN; Schultz RA; Berry-Kravis E; Porter BE; Falk M; Venkat A; Vanzo RJ; Cohen JS; Fatemi A; Dobyns WB; Shaffer LG; Ballif BC; Marsh ED Neurogenetics; 2013 May; 14(2):99-111. PubMed ID: 23389741 [TBL] [Abstract][Full Text] [Related]
13. Genetic Suppression of mTOR Rescues Synaptic and Social Behavioral Abnormalities in a Mouse Model of Pten Haploinsufficiency. Huang WC; Chen Y; Page DT Autism Res; 2019 Oct; 12(10):1463-1471. PubMed ID: 31441226 [TBL] [Abstract][Full Text] [Related]
14. Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory. Adachi M; Lin PY; Pranav H; Monteggia LM Biol Psychiatry; 2016 Jul; 80(2):140-148. PubMed ID: 26642739 [TBL] [Abstract][Full Text] [Related]
15. A Novel Human Stephenson JR; Wang X; Perfitt TL; Parrish WP; Shonesy BC; Marks CR; Mortlock DP; Nakagawa T; Sutcliffe JS; Colbran RJ J Neurosci; 2017 Feb; 37(8):2216-2233. PubMed ID: 28130356 [TBL] [Abstract][Full Text] [Related]
16. An essential role for MEF2C in the cortical response to loss of sleep in mice. Bjorness TE; Kulkarni A; Rybalchenko V; Suzuki A; Bridges C; Harrington AJ; Cowan CW; Takahashi JS; Konopka G; Greene RW Elife; 2020 Aug; 9():. PubMed ID: 32851972 [TBL] [Abstract][Full Text] [Related]
17. MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review. Rocha H; Sampaio M; Rocha R; Fernandes S; Leão M Eur J Med Genet; 2016 Sep; 59(9):478-82. PubMed ID: 27255693 [TBL] [Abstract][Full Text] [Related]
18. Direct targets of MEF2C are enriched for genes associated with schizophrenia and cognitive function and are involved in neuron development and mitochondrial function. Ali D; Laighneach A; Corley E; Patlola SR; Mahoney R; Holleran L; McKernan DP; Kelly JP; Corvin AP; Hallahan B; McDonald C; Donohoe G; Morris DW PLoS Genet; 2024 Sep; 20(9):e1011093. PubMed ID: 39259737 [TBL] [Abstract][Full Text] [Related]
19. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice. Xue F; Tian J; Yu C; Du H; Guo L Neurobiol Dis; 2021 May; 152():105272. PubMed ID: 33540048 [TBL] [Abstract][Full Text] [Related]
20. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Arrant AE; Filiano AJ; Patel AR; Hoffmann MQ; Boyle NR; Kashyap SN; Onyilo VC; Young AH; Roberson ED Neurobiol Dis; 2019 Apr; 124():152-162. PubMed ID: 30448285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]